Supplementary Table S2 from First-in-Human Phase I/IIa Study of the First-in-Class CDK2/4/6 Inhibitor PF-06873600 Alone or with Endocrine Therapy in Patients with Breast Cancer
Authors:
- Timothy A. YapTYTimothy A. Yap
- Jonathan W. GoldmanJGJonathan W. Goldman
- Shaveta VinayakSVShaveta Vinayak
- Antoaneta TomovaATAntoaneta Tomova
- Erika HamiltonEHErika Hamilton
- Yoichi NaitoYNYoichi Naito
- Antonio GiordanoAGAntonio Giordano
- Igor BondarenkoIBIgor Bondarenko
- Toshinari YamashitaTYToshinari Yamashita
- Li ZhouLZLi Zhou
- Allison MoreauAMAllison Moreau
- Heather NeumannHNHeather Neumann
Open Access
- 15 July 2025
- other
- Published by American Association for Cancer Research (AACR)